Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM(@agingdoc1):A randomized double-blind placebo-controlled clinical trial of a multi-target therapeutic against primary age-related feline sarcopenia: PURR-001 [ “ PURR-001 enteric capsules contained a nominal dose of 0.5 mg mTOR inhibitor, 2 mg mirtazapine and 10 mg acarbose]👇 “This is the first randomized placebo-controlled clinical trial to demonstrate the efficacy of a pharmaceutical intervention for primary age-related sarcopenia in cats, providing a foundation for larger confirmatory studies of gerotherapeutic interventions in companion animals...”

Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM@agingdoc1

2026.08.24 00:07

A randomized double-blind placebo-controlled clinical trial of a multi-target therapeutic against primary age-related feline sarcopenia: PURR-001 [ “ PURR-001 enteric capsules contained a nominal dose of 0.5 mg mTOR inhibitor, 2 mg mirtazapine and 10 mg acarbose]👇 “This is the first randomized placebo-controlled clinical trial to demonstrate the efficacy of a pharmaceutical intervention for primary age-related sarcopenia in cats, providing a foundation for larger confirmatory studies of gerotherapeutic interventions in companion animals...”